Shuyang Yao Selected Research

Melanoma (Melanoma, Malignant)

1/2021

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuyang Yao Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 10/2009
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 06/2015
2	Adenocarcinoma of Lung 07/2021 - 01/2020
2	Lymphatic Metastasis 01/2020 - 10/2010
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2023
1	Anxiety Disorders (Anxiety Disorder) 12/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2023
1	Postpartum Depression (Post-Natal Depression) 12/2023
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2023
1	Major Depressive Disorder (Major Depressive Disorders) 12/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023
1	Ovarian Epithelial Carcinoma 01/2023
1	Neoplasm Metastasis (Metastasis) 07/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Communicable Diseases (Infectious Diseases) 11/2020
1	Wilms Tumor (Wilm's Tumor) 11/2020
1	Myasthenia Gravis 08/2020
1	Neoplasm Micrometastasis 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Anorexia Nervosa 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Lung Neoplasms (Lung Cancer) 09/2016
1	Breast Neoplasms (Breast Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2022 - 01/2021
2	ADI PEG20IBA 01/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 07/2021 - 09/2016
2	Immune Checkpoint InhibitorsIBA 08/2020 - 01/2020
2	icotinibIBA 09/2016 - 06/2015
1	Tuberculin (PPD)IBA 12/2023
1	adavosertibIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Cyclin EIBA 01/2022
1	liposomal doxorubicin (Doxil)FDA Link 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	1-dodecylpyridoxal (PLD)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cancer VaccinesIBA 11/2020
1	WT1 ProteinsIBA 11/2020
1	VaccinesIBA 11/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	CrizotinibIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	LipidsIBA 01/2019
1	Pemetrexed (MTA)FDA Link 06/2015
1	Docetaxel (Taxotere)FDA Link 06/2015
1	Goserelin (Zoladex)FDA Link 01/2011
1	Hormones (Hormone)IBA 01/2011
1	Letrozole (Femara)FDA LinkGeneric 01/2011
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2011
1	Aromatase InhibitorsIBA 01/2011
1	Bortezomib (Velcade)FDA Link 10/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2009

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 07/2021 - 10/2010
4	Immunotherapy 07/2021 - 01/2020
2	Therapeutics 01/2022 - 07/2021
2	Radiotherapy 11/2020 - 10/2010
1	Intravenous Infusions 01/2022
1	Neoadjuvant Therapy 01/2020